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Nitric oxide was recently demonstrated to stimulate ADP-ribosylation of glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Our studies on 
the effect of glyceraldehyde-3-phosphate (GA3P), the natural substrate of dehydrogenase activity of GAPDH. indicated GA3P to be another very 
potent activator of ADP-ribosylation of the enzyme. GA3P was able to activate ADP-nbosylation only m the presence of DTT. The action of GA3P 
was associated with inhibition of GAPDH dehydrogenase activity K, for GA3P was at least 50-fold lower and maximal activation was somewhat 
higher than these values for other aldehydes that were also able to enhance GAPDH ADP-ribosylation in the presence of DTT. ADP-ribosylation 
was blocked by carboxamidomethylation of the essential cysteme SH-group. The bond between the prelabeled protein and ADP-ribose was resistant 
to hydrolysis with hydroxylamine and HgCl?. suggesting that a lysme e-amino group is the target for ADP-ribosylation. 
ADP-ribosylation; Glyceraldehyde-3-phosphate; Glyceraldehyde-3-phosphate dehydrogenase 
1. INTRODUCTION 2. MATERIALS AND METHODS 
NAD’ is a cofactor of many dehydrogenases. In the 
mean time NAD’ can be cleaved by ADP-ribosyl trans- 
ferases so that the ADP-ribose moiety becomes attached 
to an amino acid acceptor residue in target proteins. 
ADP-ribosyl transferase activity is attributable to di- 
verse bacterial toxins. Also intracellular or endogenous 
ADP-ribosylation reactions have been shown to exist in 
vivo [1,2]. Recently the substrate of nitric oxide-acti- 
vated ADP-ribosylation has been described in many cell 
types [3]. The protein was purified and identified as 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 
by Kots et al. [4]. Dimmeler et al. [5], and Zhang and 
Snyder [6]. ADP-ribosylation of GAPDH may be in- 
volved in the NO-mediated cGMP-independent inter- 
cellular signalling in blood vessels, macrophage and 
neuron cytotoxicity [7], as well as the hepatocyte metab- 
olism suppression [S]. 
In the present study we have found that ADP-ribosyl- 
ation of GAPDH is activated not only by nitric oxide, 
but also by D-glyceraldehyde-3-phosphate (GA3P), the 
natural substrate for dehydrogenase activity of 
GAPDH, and other aldehydes. 
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2.1 Muteriuls 
[Adenylate-Z’P]NAD’ (1000 Cllmmol) was synthesized from 
[~I-~‘P]ATP (Amersham, UK) as described [9]. [‘4C]Iodoacetamide (52 
mCt/mmol) was purchased from Amersham, UK. Reagents for elec- 
trophoresis were from Bto-Rad. USA. GA3P. o-glyceraldehyde and 
NAD’ were from Serva, Germany. All other reagents were of the 
analytical grade. 
GAPDH was extracted from rabbit muscle and the extract was 
fractionated as described [lo]. The acyl group was removed from the 
enzyme’s active site by incubation in 20 mM Trts-HCl (pH 7.4) con- 
taining 0.3 mM NAD’ and 0.4 mM sodium arsenate at 25°C for 10 
min [l 11. GAPDH was further recrystallized by addttion of saturated 
ammomum sulfate (pH 8.2) four times. GAPDH preparations (20 pg) 
exhibited no detectable impurities in SDS-PAGE analysis. Before the 
assays, the enzyme was incubated with loo-fold excess of NAD’ in 
order to displace possible ADP-ribose present in the coenzyme-bind- 
mg site [l l] and desalted by passing through a Sephadex G-50 column 
equthbrated with 20 mM Tris-HCl (pH 7.5). Routinely thts prepara- 
tton contained 3.5-3.9 moles of NAD’ per mole of tetramer The 
enzyme and nucleotide concentrations were determined spectro- 
photometrically from the A2soIA2,, ratio [12]. 
2.2. [“PIADP-rlbos~lutron crssa!, 
GAPDH (2 pug) was added to the incubation mixture (final volume 
40 ~1) containing 20 mM Tns-HCl (pH 7.5). 10 mM dithtothreitol 
(DTT). 2 PM NAD’, 1 PCi [“PINAD’. 0.1 mM nitroprusslde, or 0.5 
mM GA3P. or other aldehydes as Indicated. Incubation was carried 
out for 1 h at 37°C and the reaction was stopped by the addttion of 
the denaturation mtxture [13]. Samples were boiled for 3 mm and 
electrophoresed through 11% SDS-PAGE by the method of Laemmh 
[14]. Gels were fixed, stamed wtth Coomassie R-250, destained m 
boiling water and dried. Dry gels were exposed to Amersham Hyper- 
film MP (preflashed) m the intensifying screen cassette for 20 h. Bands 
of interest were excised from the gel and counted by liquid scintilla- 
tion. Relative extent of labeling was also quantified by densttometry 
of autoradiograms (three times each lane) wtth subsequent determina- 
tion of peak areas using an Ultroscan XL laser densttometer (LKB, 
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Sweden) linked to an Olivetti M-290 personal computer driven by 
Gelscan XL software. The hnearity of peak area versus degree of 
labeling was verified in a separate experiment. 
2.3. Other assq~s 
GAPDH was carboxamtdomethylated in 20 mM sodtum pyro- 
phosphate (pH 8.5) Samples contaming 10 ,uM enzyme and 100 ,uM 
[“‘Cliodoacetamide were Incubated for suttable ttme intervals (0.5515 
min) at 2O’C. Modtficatton was stopped by addttton of DTT to a final 
concentratton of 10 mM, and [“PIADP-rrbosylation of GAPDH in the 
presence of 1 mM glyceraldehyde and 10 mM DTT was assayed. 
Dehydrogenase activity of GAPDH was measured at 35°C m 50 
mM potassium phosphate, 50 mM glycine (pH 9.0), 0.5 mM NAD’ 
and 0.5 mM GA3P. Reaction uas started by addition of 1 flcg of 
GAPDH and increase m absorbance at 340 nm was esttmated. 
All experiments were repeated three times and means + S.E.M. 
(P < 0.05) are presented. 
3. RESULTS AND DISCUSSION 
Nitroprusside-activated ADP-ribosylation of 
GAPDH from human erythrocytes [4] and other 
sources [6] is known to be characterized by low stoi- 
chiometry. To find the proper explanation of this fact 
we have studied the effect of GA3P, the natural sub- 
strate for dehydrogenase activity of GAPDH, on its 
ADP-ribosylation. Nitroprusside did greatly stimulate 
(approx. 20-fold) ADP-ribosylation of the rabbit mus- 
cle enzyme (Fig. 1). When the protein was incubated in 
the presence of both nitroprusside and GA3P, the label- 
ing of the 37 kDa polypeptide was reduced 6-fold. The 
inhibition of the nitroprusside action may be the result 
of rapid inter-reaction of nitroprusside with the alde- 
hyde, thus preventing NO liberation and, at the same 
time, inactivating GA3P [15]. The effect of NO on ADP- 
ribosylation was unexpectedly mimicked by GA3P. The 
label incorporation dramatically increased approx. 25- 
fold in samples containing both GA3P and DTT rela- 
tive to the control samples containing DTT alone (Fig. 
1). Thus, apart from nitric oxide, ADP-ribosylation of 
GAPDH is also activated by GA3P in a manner similar 
36kDae 
DTT - + + + + - 
Nitroprusside + - * + - - 
GA3P - - - + l l 
Fig. 1. Effects of nitroprusside, GA3P, and DTT on ADP-ribosylation 
of GAPDH. SNP, sodium nitroprusside. ADP-ribosylation was as- 
sayed as described in section 2.2, and the autoradiogram shown is 
representattve of four experiments. 
to the nitroprusside-dependent modification, as GA3P 
exerts its effect only in the presence of DTT. Moreover, 
one can suggest that in this case auto-modification of 
the enzyme occurs, because the GAPDH preparation 
used showed no detectable impurities, 
The effect of GA3P was time-dependent (Fig. 2A). 
Following a 20 min lag-period. rapid increase in ADP- 
ribose incorporation was observed and a stable plateau 
was reached after 1.5 h incubation. Dehydrogenase ac- 
tivity of GAPDH was tested in parallel (Fig. 2B) and 
found to be inhibited under the same conditions used 
for ADP-ribosylation assay. It is noteworthy that the 
inhibition had approx. the same lag-period (about 20 
min) followed by rapid inactivation up to 70% of con- 
trol samples’ activity after 1 h of incubation. This fact 
suggests that GAPDH may be inhibited due to ADP- 
ribosylation, but that is not apparently true because 
only 4 + 1% of GAPDH tetramers were ADP-ribosyl- 
ated. while dehydrogenase activity was inhibited by 
Ftg. 2. Ttme-dependent activation of GAPDH ADP-rtbosylatton and inhibition of enzyme dehydrogenase activity by GA3P. GAPDH was 
incubated in the presence of GA3P and DTT as described m section 2.2. At mdtcated time intervals aliquots were either analyzed by SDS-PAGE 
and [“P]ADP-rtbosylation was esttmated by laser densitometry of autoradiograms (A). or assayed for dehydrogenase activity (B). Protein treated 
wtth 10 mM DTT served as the control. The data shown are representattve of three experiments. 
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Fig. 3. Effect of GA3P concentration on GAPDH ADP-ribosylation 
Protein was incubated m the presence of 10 mM DTT and GA3P 
concentrations as indicated. Label incorporation was counted by hq- 
uid scintillation. 
28 f 3%. More likely, ADP-ribosylation is the result of 
change in the conformation of either all or part of en- 
zyme molecules in the presence of GA3P and DTT. 
The effect of GA3P on GAPDH ADP-ribosylation 
was concentration-dependent (Fig. 3). K, value esti- 
mated was 2.7 ? 1.9 ,uM (Table I). This is almost 20- 
fold lower than the K,,, value for dehydrogenase activity 
of GAPDH [lo]. Thus ADP-ribosylation is probably 
unrelated to oxidation of GA3P, as well as to phosphor- 
olysis of the acylated enzyme, because phosphate and 
arsenate in concentrations up to 20 mM had no effect 
on GA3P-activated ADP-ribosylation (data not 
shown). 
To assess the specificity of GA3P effect relative to 
other compounds. the ability of several aldehydes listed 
in Table I to promote ADP-ribosylation of GAPDH 
was tested. All substances were able to activate modifi- 
cation in the DTT-dependent manner. These aldehydes 
had K, values at least 50-fold higher than that of GA3P, 
and their maximal effect on ADP-ribosylation was at 
least 1.5-fold less. Thus we conclude that GA3P is a 
specific stimulator of GAPDH ADP-ribosylation. 
Table I 
Activation of GAPDH ADP-rtbosylation by aldehydes 
Substance K, OtM) Maximal activatton 
(% of control) 
GA3P 
Glyceraldehyde 
Benzaldehyde 
Salicyhc aldehyde 
Glycolic aldehyde 
2.1 k 1.9 2340 + 275 
120 + 10 1692 + 106 
305 f 110 229 ir 139 
1750 * 300 298 f 139 
2200 k 900 714 k 61 
GAPDH was ADP-rtbosylated in the presence of 10 nM - 25 mM of 
Indicated compound, label incorporation was measured by densttom- 
etry of autoradiograms, and K, value was calculated. Maximal activa- 
tion was estimated in the presence of 5 mM of indicated compound, 
and radioactivity was counted by liquid scintillation. 
As shown in Fig. 4, aldehyde-induced ADP-ribosyla- 
tion was strongly inhibited by carboxamidomethylation 
of GAPDH. The essential CYS’~~ SH-group in the active 
site of enzyme is known to react with iodoacetamide 
[16]. We suppose that this SH-group is involved in 
ADP-ribosylation. Furthermore. the non-linear con- 
cave shape of the inhibition curve suggests that the 
tetramer subunits interaction plays a certain role in 
ADP-ribosylation. The stimulatory effect of GA3P was 
not observed on the dimeric enzyme from human eryth- 
rocytes (data not shown) used instead of the rabbit 
muscle tetramer, so the intact quaternary structure of 
GAPDH is evidently necessary for ADP-ribosylation. 
Nitroprusside was shown to activate cysteine-specific 
ADP-ribosylation of GAPDH [4,6,20]. In contrast to 
this, in the case of GA3P- as well as glyceraldehyde- 
stimulated ADP-ribosylation the bond between the pro- 
tein and ADP-ribose was not significantly hydrolyzed 
by the treatment of the prelabeled protein with HgCl, 
or hydroxylamine, but was cleaved by phosphod- 
iesterase (Table II). This fact indicates that the modified 
amino acid residue is neither arginine, asparagine, cys- 
teine nor a carboxyl group, because these amino acids 
form bonds with ADP-ribose known to be cleaved by 
NH,OH or HgCl, [17]. An alternative may be a lysine 
residue E-amino group, whose conjugates with ADP- 
ribose are resistant to hydrolysis conditions indicated in 
Table II [18]. The possibility that a lysine residue is 
ADP-ribosylated in GAPDH has been mentioned by 
other authors [19]. In general our results indicate that 
nitric oxide is not unique in its ability to promote ADP- 
ribosylation of GAPDH. Although aldehydes induce 
apparently lysine-specific ADP-ribosylation, while NO 
activates cysteine-specific modification, the strong simi- 
larity between these modifications exists in requirement 
for DTT and for the intact essential SH-group ([20] and 
Fig. 4). Nevertheless it is possible to propose that alde- 
Ftg. 4. Inhibttion of glyceraldehyde-stimulated ADP-ribosylation by 
carboxamtdomethylatton. GAPDH was Incubated with [‘4C]iodoacet- 
amide and then [“PIADP-ribosylated as described m section 2.3. Gel 
was dissolved m 30% H20Z, 1% NH,OH and dual label was counted 
by liquid scintrllation Correlation coefficient between ?I- and “P- 
label mcorporatton was -0.98 + 0.28. (P < 0.05). 
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Table II 
Stability of the bond between GAPDH and ADP-rtbose 
Acttvator used Radioactivity remaining bound to GAPDH after 
for stimulating indicated treatment of prelabeled protein 
ADP-ribosyla- (% of control) 
tion 
Hydroxylamme H&l2 Phospho- 
dtesterase 
Nitroprusside. 942 14 5f 12 <2 
0.1 mM 
GA3P, 0.5 mM 91 f8 68 + 7 <2 
Glyceraldehyde, 88 * 11 792 19 <2 
1 mM 
ADP-ribosylatton assays were stopped by addition of 5% trtchlo- 
roacetic acid. 0.1% bovine serum albumin. Protein was pelleted and 
resuspended in 0.1 M HEPES-NaOH (pH 7.5) and treated with 1 M 
hydroxylamine (pH 7.0) for 3 h, 1 mM or 10 mM HgCIZ for 30 mm. 
or with 50 ,&ml snake venom phosphodtesterase. 10 mM MgCl, for 
30 min at 37°C. Protein was repelleted, samples were electrophoresed, 
and label mcorporation was measured by densitometry of auto- 
radiograms. 
hydes may non-selectively react with many amino acid 
residues and hence cause NAD’ cleavage with the sub- 
sequent ADP-ribose transfer. 
The functional significance of GAPDH auto ADP- 
ribosylation is presently unknown. This modification 
may affect not only dehydrogenase activity of the en- 
zyme but also other functions of GAPDH including the 
triad junction formation [21], tRNA translocation ca- 
talysis [22], and uridine DNA glycosylase activity [23]. 
Thus GAPDH being the multifunctional protein may be 
regulated via its ADP-ribosylation by intracellular con- 
centrations of NO, GA3P, other aldehydes and reduced 
thiol-containing agents. 
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